CRSR Q1 2026 Earnings Strong EPS Beat Signals Operational Discipline BYRN Q1 2026 Earnings EPS Misses Estimates Stock Advances on Strategic Progress Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises AudioCodes Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CRDL Q4 2025 Earnings Narrower Than Expected Loss as Cardiol Therapeutics Advances Clinical Pipeline